Previous  bell    Next
bell Warning: JavaScript is turned off! Some features on this website will not work without it.

Trojan Email Claiming EFax Received from J2 Global Communications

Here is a malicious e-mail with a dangerous Trojan horse attached, claiming that the victim received eFax sent by J2 Global Communications. The email appeared as if it came from an e-mail address at linkedin.com, but it was not sent from there.
Trojan Email Claiming EFax Received from J2 Global Communications
Online Threat Alerts

Trojan Email Claiming EFax Received from J2 Global Communications


Rating - Thumb up Rating - Thumb down 0   
Trojan Email Claiming EFax Received from J2 Global Communications

Here is a malicious e-mail with a dangerous Trojan horse attached, claiming that the victim received eFax sent by J2 Global Communications. The email appeared as if it came from an e-mail address at linkedin.com, but it was not sent from there.

Please continue reading below.

A Sample of the Malicious Email

Fax Message [Caller-ID: 837091732]

You have received a 27 pages fax at Tue, 12 Feb 2013 05:11:17 -0500, (578)-746-6998.

* The reference number for this fax is [eFAX-062107024].

View attached fax using your Internet Browser.

© 2013 j2 Global Communications, Inc. All rights reserved.
eFax is a registered trademark of j2 Global Communications, Inc.

This account is subject to the terms listed in the eFax ? Customer Agreement.

The name of the attachment is: Efax_Corporate.htm. Do not open the attachment, it is a Trojan horse called JS:Redirector-AGO.

Remember to leave your comment and read the ones made by others below. And, please report malicious, phishing or scam email messages, social media posts and websites to us. You may click here to contact us, or forward the email messages to: info@onlinethreatalerts.com .

Alert and help your family and friends by sharing this article with them:
Submit Your Comment or Question

Submit your comment or question in the box below to share what you know or to get answers about this article.

CommentComments or Questions (0)